Tuesday, July 25, 2017
Brian Keith May

Will Google’s Second Attempt In Healthcare Succeed?

Brian May September 24, 2013 Uncategorized Comments Off on Will Google’s Second Attempt In Healthcare Succeed?

Google Calico

Google recently announced that they are getting back into healthcare through a new company they are funding named Calico. The press release states the new company will focus on health and well-being, in particular the challenge of aging and associated diseases. This is Google’s second attempt at entering the healthcare space after discontinuing Google Health a few years ago.

Besides naming a CEO, there were not a lot of details shared about this new effort outside of saying it would attempt to fight aging. That is a very lofty goal! Sadly, those are the types of goals that sound great at first, but within a few years lose steam and fall by the wayside. My guess is that Google will attempt to us aggregated data to attempt to solve medical issues. The first step will likely be a deeper involvement with 23andme, which they previously funded, which provides genetic testing. That may be a little tricky as 23andme was founded by Ann Wojcicki who is currently going through a divorce from Google co-founder Sergey Brin, Ironclad prenups are likely in place which should make the process easy and Sergey Brin was not mentioned as involved in the project so another way it should be easy.

If anyone has to the resources to take on this problem, it’s Google. The problem lies in if the approach is right. Can large amounts of data leads to solutions of medical problems? In theory, it should work perfectly. Now it’s time to see it work in practice.

Is Google taking on an issue that is too big to conquer or do you think they will have some success in the fight against aging?

 

Like this Article? Share it!

About The Author

Brian May is the owner of Daymark Interactive . He has great passion for marketing with particular focus and experience in Healthcare and Education. Get in Touch via our Contact Page or on Google+

Comments are closed.